Cizzle Biotechnology Holdings PLC Posting of Annual Report and Notice of AGM (6769B)
05 Junio 2023 - 6:35AM
UK Regulatory
TIDMCIZ
RNS Number : 6769B
Cizzle Biotechnology Holdings PLC
05 June 2023
5 June 2023
Cizzle Biotechnology Holdings Plc
("Cizzle Biotechnology", "Cizzle" or the "Company")
Posting of Annual Report and Notice of AGM
Cizzle Biotechnology, the UK-based diagnostics developer, is
pleased to announce that copies of the annual report and accounts
for the year ended 31 December 2022, together with the notice of
Annual General Meeting ("AGM"), have been sent to shareholders and
are available for viewing on the Company's website at
https://cizzlebiotechnology.com .
The AGM of Cizzle Biotechnology will be held at 11.00 a.m. BST
on 28 June 2023 at the offices of Shakespeare Martineau LLP, 6(th)
Floor, 60 Gracechurch Street, London, EC3V 0HR.
Enquiries:
Cizzle Biotechnology Holdings Via IFC Advisory
plc
Allan Syms (Executive Chairman)
Allenby Capital Limited +44(0) 20 33285656
John Depasquale
Alex Brearley
Novum Securities Limited +44(0) 20 7399 9400
Colin Rowbury
Jon Bellis
IFC Advisory Limited +44(0) 20 3934 6630
Tim Metcalfe cizzle@investor-focus.co.uk
Florence Chandler
About Cizzle Biotechnology
Cizzle Biotechnology is developing a blood test for the early
detection of lung cancer. Cizzle Biotechnology is a spin- out from
the University of York, founded in 2006 around the work of
Professor Coverley and colleagues. Its proof-of-concept prototype
test is based on the ability to detect a stable plasma biomarker, a
variant of CIZ1 known as CIZ1B. CIZ1 is a naturally occurring cell
nuclear protein involved in DNA replication, and the targeted CIZ1B
variant is highly correlated with early-stage lung cancer. For more
information, please see https://cizzlebiotechnology.com You can
also follow the Company through its twitter account @CizzlePlc and
on LinkedIn.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOANKPBNDBKDPAK
(END) Dow Jones Newswires
June 05, 2023 07:35 ET (11:35 GMT)
Cizzle Biotechnology (LSE:CIZ)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Cizzle Biotechnology (LSE:CIZ)
Gráfica de Acción Histórica
De May 2023 a May 2024